 HOLON, Israel, March 9, 2022 PRNewswire -- Compugen Ltd. NASDAQ: CGEN, a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, today announced that management will present at the Oppenheimer 32nd Annual Global Healthcare Conference virtual, on Wednesday, March 16, 2022 at 11:20 am ET. 